Stocks and Investing Stocks and Investing
Thu, January 3, 2019
Wed, January 2, 2019
Mon, December 31, 2018

Joseph Pantginis Maintained (CAPR) at Strong Buy with Decreased Target to $35 on, Dec 31st, 2018


Published on 2024-10-26 11:25:17 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Maintained "Capricor Therapeutics, Inc." (CAPR) at Strong Buy with Decreased Target from $86 to $35 on, Dec 31st, 2018.

Joseph, nor any peers, have made any analyst calls on CAPR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources